Antares Pharma, Inc.
ATRSDelisted May 24, 2022- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001016169
Antares Pharma, Inc. was delisted on May 24, 2022; its insiders filed their last Form 4 on May 26, 2022; 177 institutions reported holding it in 13F filings for Q1 2022, worth $374.8M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Antares Pharma, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Antares Pharma, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Jacob Leonard S | Director | 0 | May 26, 2022 | 0 |
| Apple Robert F | President and CEO | 0 | May 26, 2022 | 0 |
| Roche Robert P Jr | Director | 0 | May 26, 2022 | 0 |
| Graham Peter J | See Remarks | 0 | May 26, 2022 | 0 |
| Gueth Anton | Director | 0 | May 26, 2022 | 0 |
| Garrity Thomas J | Director | 0 | May 26, 2022 | 0 |
| Volkart Carmen B | Director | – | May 26, 2022 | 0 |
| Powell Fred M | Executive Vice President & CFO | 0 | May 26, 2022 | 0 |
| Richardson Peter C | See Remarks | 0 | May 26, 2022 | 0 |
| Greenleaf Peter | Director | 0 | May 26, 2022 | 0 |
| Smith Karen L. | Director | 0 | May 26, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 9, 2021 (view filing) | Jul 8 | 1 day | Gueth AntonDirector | SSale | −100.0K | $4.29 | −$429.0K | −17.6%467.6K after |